Cargando…

Overactive Bladder: Pathophysiology, Diagnostics, and Therapies

Detalles Bibliográficos
Autores principales:	Heesakkers, John P. F. A., Cruz, Francisco, Igawa, Yasuhiko, Kocjancic, Ervin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384922/ https://www.ncbi.nlm.nih.gov/pubmed/22761613 http://dx.doi.org/10.1155/2011/863504

Ejemplares similares

Pathophysiology of the underactive bladder
por: Aizawa, Naoki, et al.
Publicado: (2017)

Beta3-Adrenoceptor Agonists: Possible Role in the Treatment of Overactive Bladder
por: Igawa, Yasuhiko, et al.
Publicado: (2010)

Solifenacin in Multiple Sclerosis Patients with Overactive Bladder: A Prospective Study
por: van Rey, Farida, et al.
Publicado: (2011)

Safety and Tolerability of Fesoterodine in Older Adult Patients with Overactive Bladder
por: Heesakkers, John, et al.
Publicado: (2022)

Long-term adherence to clinical therapy of overactive bladder
por: Drake, Marcus John
Publicado: (2017)

Effectiveness of percutaneous tibial nerve stimulation in the treatment of overactive bladder syndrome
por: de Wall, Liesbeth L, et al.
Publicado: (2017)

Augmentation cystoplasty in neurogenic bladder
por: Çetinel, Bülent, et al.
Publicado: (2016)

Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements
por: Javan Balegh Marand, Aida, et al.
Publicado: (2023)

Real-life patient experiences of TTNS in the treatment of overactive bladder syndrome
por: te Dorsthorst, Manon, et al.
Publicado: (2021)

Current pharmacotherapy of overactive bladder
por: Kreydin, Evgenyi I., et al.
Publicado: (2021)

Clinical utility of neurostimulation devices in the treatment of overactive bladder: current perspectives
por: Janssen, Dick AW, et al.
Publicado: (2017)

Overactive bladder syndrome: Current pathophysiological concepts and therapeutic approaches
por: Osman, Nadir I., et al.
Publicado: (2013)

Urinary Tract Infection in Overactive Bladder: An Update on Pathophysiological Mechanisms
por: Mansfield, Kylie J., et al.
Publicado: (2022)

Drugs for the overactive bladder: are there differences in persistence and compliance?
por: Andersson, Karl-Erik
Publicado: (2017)

Dealing with complex overactive bladder syndrome patient profiles with focus on fesoterodine: in or out of the EAU guidelines?
por: Heesakkers, John, et al.
Publicado: (2017)

Alterations of the Myovesical Plexus of the Human Overactive Detrusor
por: Kuijpers, Kamiel A. J., et al.
Publicado: (2014)

Metabolic Syndrome and Overactive Bladder Syndrome May Share Common Pathophysiologies
por: Hsu, Lin-Nei, et al.
Publicado: (2022)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Patient‐tailored healthcare and tibial nerve neuromodulation in the treatment of patients with overactive bladder symptoms
por: te Dorsthorst, Manon, et al.
Publicado: (2022)

Overactive bladder in the vulnerable elderly
por: Wolff, Gillian F, et al.
Publicado: (2014)

Cardiovascular safety of antimuscarinic add‐on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A post hoc analysis from the Japanese MILAI II study
por: Katoh, Takao, et al.
Publicado: (2019)

Future directions in overactive bladder treatment: Personalized medicine can be applied?
por: Lee, Kyu-Sung
Publicado: (2015)

Validation of a Dutch version of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: an observational web-based study
por: Jongen, Peter Joseph, et al.
Publicado: (2015)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

A watershed paper for surgical cure of overactive bladder and nocturia
por: Petros, Peter
Publicado: (2021)

Update on the management of overactive bladder
por: Fontaine, Christina, et al.
Publicado: (2021)

Overactive Bladder Disease: The Urge for Better Therapies
por: Thomas, Lisa, et al.
Publicado: (2008)

Biomarkers in Overactive Bladder: A New Objective and Noninvasive Tool?
por: Antunes-Lopes, Tiago, et al.
Publicado: (2011)

Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014)

Simplified scoring of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: a comparative analysis of test performance at different cut-off points
por: Jongen, Peter Joseph, et al.
Publicado: (2015)

Diagnostic Tool for Assessing Overactive Bladder Symptoms: Could the International Prostate Symptom Storage Subscore Replace the Overactive Bladder Symptom Score?
por: Shim, Ji Sung, et al.
Publicado: (2016)

Profile of mirabegron in the treatment of overactive bladder: place in therapy
por: Sharaf, Ala’a, et al.
Publicado: (2017)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
por: Tannenbaum, Stacey, et al.
Publicado: (2020)

Third‐line therapy for overactive bladder in the elderly: Nuances and considerations
por: Zillioux, Jacqueline, et al.
Publicado: (2022)

Refractory overactive bladder: Beyond oral anticholinergic therapy
por: Glinski, Ronald W., et al.
Publicado: (2007)

Drug therapy of overactive bladder - What is coming next?
por: Andersson, Karl-Erik
Publicado: (2015)

Intradetrusor botulinum toxin type A in refractory overactive bladder: A potential future treatment
por: Mahajan, Rajiv, et al.
Publicado: (2011)

Pharmacologic management of overactive bladder
por: Lam, Sum, et al.
Publicado: (2007)

Medical management of overactive bladder
por: Ubee, Sarvpreet S., et al.
Publicado: (2010)

Urinary biomarkers of overactive bladder
por: Tian, Xiao-Jun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0grhtaq3pko0hk719altl9or9g